FTX-214/FTX-218/FTX-219

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFTX-214/FTX-218/FTX-219
Drug Alias NameFTX-214/FTX-218/FTX-219
ClassificationOther
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsGlycoproteins stimulantsNuclear factor erythroid 2-related factor 2 stimulants
TargetsNuclear factor erythroid 2-related factor 2Nuclear factor NF-kappa-B complexGlycoproteins
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A